Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 364-370

  Short, Kirsty R ^a,g   von Köckritz Blickwede, Maren ^b   Langereis, Jeroen D ^c   Chew, Keng Yih ^a   Job, Emma R ^a   Armitage, Charles W ^d   Hatcher, Brandon ^e   Fujihashi, Kohtaro ^e   Reading, Patrick C ^a,f   Hermans, Peter W ^c   Wijburg, Odilia L ^a   Diavatopoulos, Dimitri A ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL LOAD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; INFLUENZA A; INFLUENZA VIRUS A; MIDDLE EAR; MIXED INFECTION; MOUSE; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; VIRUS LOAD;

EID: 84890835297     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01104-13     Document Type: Article

References (46)

1. Cripps A, Otczyk D, Kyd J. 2005. Bacterial otitis media: a vaccine preventable disease? Vaccine 23:2304-2310. http://dx.doi.org/10.1016/j.vaccine.2005.01.023.
2. Massa HM, Cripps AW, Lehmann D. 2010. Otitis media: viruses, bacteria, biofilms and vaccines. Med. J. Aust. 191:S44-S49.
3. Short KR, Diavatopoulos DA, Thornton R, Pedersen J, Strugnell RA, Wise AK, Reading PC, Wijburg OL. 2011. Influenza virus induces bacterial and nonbacterial otitis media. J. Infect. Dis. 204:1857-1865. http://dx.doi.org/10.1093/infdis/jir618.
4. Chonmaitree T, Owen M, Howie V. 1990. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J. Infect. Dis. 162:546-549. http://dx.doi.org/10.1093/infdis/162.2.546.
5. Giebink GS, Berzins IK, Marker SC, Schiffman G. 1980. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30:445-450.
6. McCullers JA, Karlström Å, Iverson AR, Loeffler JM, Fischetti VA. 2007. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathol. 3:e28. http://dx.doi.org/10.1371/journal.ppat.0030028.
7. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA. 2006. Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets. Infect. Immun. 74:2562-2567. http://dx.doi.org/10.1128/IAI.74.5.2562-2567.2006.
8. Short KR, Reading PC, Brown LE, Pedersen J, Gilbertson B, Job ER, Edenborough KM, Habets MN, Zomer A, Hermans PWM, Diavatopoulos DA, Wijburg OL. 2013. Influenza-induced inflammation drives pneumococcal otitis media. Infect. Immun. 81:645-652. http://dx.doi.org/10.1128/IAI.01278-12.
9. Jecker P, Pabst R, Westermann J. 1996. The mucosa of the middle ear and eustachian tube in the young rat: number of granulocytes, macrophages, dendritic cells, NK cells and T and B lymphocytes in healthy animals and during otitis media. Acta Otolaryngol. 116:443-450. http://dx.doi.org/10.3109/00016489609137871.
10. Maeda K, Hirano T, Ichimiya I, Kurono Y, Suzuki M, Mogi G. 2004. Cytokine expression in experimental chronic otitis media with effusion in mice. Laryngoscope 114:1967-1972. http://dx.doi.org/10.1097/01.mlg.0000147930.29261.51.
11. Sato K, Liebeler CL, Quartey MK, Le CT, Giebink GS. 1999. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect. Immun. 67:1943-1946.
12. Abramson JS, Giebink GS, Quie PG. 1982. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect. Immun. 36:289-296.
13. Hill HR, Book LS, Hemming VG, Herbst JJ. 1977. Defective neutrophil chemotactic responses in patients with recurrent episodes of otitis media and chronic diarrhea. Am. J. Dis. Child. 131:433.
14. Reid SD, Hong W, Dew KE, Winn DR, Pang B, Watt J, Glover DT, Hollingshead SK, Swords WE. 2009. Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas. J. Infect. Dis. 199:786-794. http://dx.doi.org/10.1086/597042.
15. Juneau RA, Pang B, Weimer KED, Armbruster CE, Swords WE. 2011. Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps. Infect. Immun. 79:431-438. http://dx.doi.org/10.1128/IAI.00660-10.
16. Thornton RB, Wiertsema SP, Kirkham L-AS, Rigby PJ, Vijayasekaran S, Coates HL, Richmond PC. 2013. Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media-a potential treatment target. PLoS One 8:e53837. http://dx.doi.org/10.1371/journal.pone.0053837.
17. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532-1535. http://dx.doi.org/10.1126/science.1092385.
18. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B. 2007. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell. Microbiol. 9:1162-1171. http://dx.doi.org/10.1111/j.1462-5822.2006.00857.x.
19. Faden HS. 1997. Immunology of the middle ear: role of local and systemic antibodies in clearance of viruses and bacteria. Ann. N. Y. Acad. Sci. 830:49-60. http://dx.doi.org/10.1111/j.1749-6632.1997.tb51878.x.
20. Briles DE, Claflin JL, Schroer K, Forman C. 1981. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature 294:88-90. http://dx.doi.org/10.1038/294088a0.
21. Palva T, Lehtinen T, Rinne J. 1983. Immune complexes in middle ear fluid in chronic secretory otitis media. Ann. Otol. Rhinol. Laryngol. 92:42-44.
22. Kitamura D, Roes J, Kühn R, Rajewsky K. 1991. AB cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423-426. http://dx.doi.org/10.1038/350423a0.
23. Diavatopoulos D, Short K, Price J, Wilksch J, Brown L, Briles D, Strugnell R, Wijburg O. 2010. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24:1789-1798. http://dx.doi.org/10.1096/fj.09-146779.
24. Short KR, Diavatopoulos DA, Reading PC, Brown LE, Rogers KL, Strugnell RA, Wijburg OLC. 2011. Using bioluminescent imaging to investigate synergism between Streptococcus pneumoniae and influenza A virus in infant mice. J. Vis. Exp. 50:e2357. http://dx.doi.org/10.3791/2357.
25. Macpherson AJ, Lamarre A, McCoy K, Harriman GR, Odermatt B, Dougan G, Hengartner H, Zinkernagel RM. 2001. IgA production without mu or delta chain expression in developing B cells. Nat. Immunol. 2:625-631. http://dx.doi.org/10.1038/89775.
26. Ghosh S, Hoselton SA, Schuh JM. 2012. μ-Chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J. Immunol. 189:1322-1329. http://dx.doi.org/10.4049/jimmunol.1200138.
27. Uren TK, Johansen FE, Wijburg OLC, Koentgen F, Brandtzaeg P, Strugnell RA. 2003. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170:2531-2539.
28. Sait LC, Galic M, Price JD, Simpfendorfer KR, Diavatopoulos DA, Uren TK, Janssen PH, Wijburg OLC, Strugnell RA. 2007. Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora. Int. Immunol. 19:257-265. http://dx.doi.org/10.1093/intimm/dxl142.
29. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Investig. Dermatol. 117:91-97. http://dx.doi.org/10.1046/j.1523-1747.2001.01340.x.
30. Moorthy AN, Narasaraju T, Rai P, Perumalsamy R, Tan K, Wang S, Engelward B, Chow VT. 2013. In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 4:56. http://dx.doi.org/10.3389/fimmu.2013.00056.
31. Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. 1992. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. JAMA 267:1947-1951. http://dx.doi.org/10.1001/jama.1992.03480140073036.
32. Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME. 1996. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51:119-125. http://dx.doi.org/10.1136/thx.51.2.119.
33. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. 1990. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc. Natl. Acad. Sci. U.S.A. 87:9188-9192. http://dx.doi.org/10.1073/pnas.87.23.9188.
34. Loch WE, Loch MH. 1962. Enzyme treatment of ear infections. Local use of pancreatic dornase. Laryngoscope 72:598-607.
35. Telethon Institute for Child Health Research. 2013. Dornase alfa study. Telethon Institute for Child Health Research. http://vaccine.childhealthresearch.org.au/clinical-trials/dornase-alfa.aspx. Accessed 28 June 2013.
36. von Köckritz-Blickwede M, Nizet V. 2009. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J. Mol. Med. 87:775-783. http://dx.doi.org/10.1007/s00109-009-0481-0.
37. Guimarães-Costa AB, Nascimento MTC, Wardini AB, Pinto-da-Silva LH, Saraiva EM. 2012. ETosis: a microbicidal mechanism beyond cell death. J. Parasitol. Res. 2012:929743. http://dx.doi.org/10.1155/2012/929743.
38. Tong HH, Li YX, Stahl GL, Thurman JM. 2010. Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2. Infect. Immun. 78:976-983. http://dx.doi.org/10.1128/IAI.01012-09.
39. Casali P, Schettino E. 1996. Structure and function of natural antibodies, p 167-179. In Potter M, Rose NR(ed), Immunology of silicones. Springer, New York, NY.
40. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, Brinkmann V, Jenne DE. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15:623-625. http://dx.doi.org/10.1038/nm.1959.
41. Eskola J, Kilpi T, Palmu A, Jokinen J, Eerola M, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409. http://dx.doi.org/10.1056/NEJM200102083440602.
42. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. 2003. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr. Infect. Dis. J. 22:10-16. http://dx.doi.org/10.1097/00006454-200301000-00006.
43. Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E. 2012. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr. Infect. Dis. J. 31:297-301. http://dx.doi.org/10.1097/INF.0b013e318247ef84.
44. Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E. 2010. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 28:6114-6121. http://dx.doi.org/10.1016/j.vaccine.2009.05.037.
45. Kadioglu A, Weiser JN, Paton JC, Andrew PW. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288-301. http://dx.doi.org/10.1038/nrmicro1871.
46. Smith-Vaughan H, Byun R, Nadkarni M, Jacques NA, Hunter N, Halpin S, Morris PS, Leach AJ. 2006. Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord. 6:10. http://dx.doi.org/10.1186/1472-6815-6-10.